Template protocol for clinical trials investigating vaccines—Focus on safety elements☆

Bonhoeffer, Jan; Imoukhuede, Egeruan B.; Aldrovandi, Grace; Bachtiar, Novilia S.; Chan, Eng-Soon; Chang, Soju; Chen, Robert T.; Fernandopulle, Rohini; Goldenthal, Karen L.; Heffelfinger, James D.; Hossain, Shah; Jevaji, Indira; Khamesipour, Ali; Kochhar, Sonali; Makhene, Mamodikoe; Malkin, Elissa; Nalin, David; Prevots, Rebecca; Ramasamy, Ranjan; Sellers, Sarah; Vekemans, Johan; Walker, Kenneth B.; Wilson, Pam; Wong, Virginia; Zaman, Khalequz; Heininger, Ulrich

doi:10.1016/j.vaccine.2013.02.041

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Template protocol for clinical trials investigating vaccines—Focus on safety elements☆

Published Date:

Mar 13 2013

Publisher's site:

http://dx.doi.org/10.1016/j.vaccine.2013.02.041 New Site Icon

Source:

Vaccine. 31(47):5602-5620.

[PDF-918.90 KB]

Details:

Personal Authors:

Bonhoeffer, Jan ; Imoukhuede, Egeruan B. ; Aldrovandi, Grace ; Bachtiar, Novilia S. ; Chan, Eng-Soon ; ... More ▼

Keywords:

[+]

Pubmed ID:

23499603

Pubmed Central ID:

PMC4586124

Description:

This document is intended as a guide to the protocol development for trials of prophylactic vaccines. The template may serve phases I-IV clinical trials protocol development to include safety relevant information as required by the regulatory authorities and as deemed useful by the investigators. This document may also be helpful for future site strengthening efforts.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

CC999999/Intramural CDC HHS/United States

Main Document Checksum:

[+]

Supporting Files:

	NIHMS723119-supplement-Supplement.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
	nihms723119.nxml	application/octet-stream
	nihms723119u1.jpg	image/jpeg

No Related Documents.

You May Also Like:

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)*

Personal Author:

Chen, Robert T.; Carbery, Baevin; Mac, Lisa; Chapman, Louisa E.; Condit, Richard C.; Excler, Jean-Louis; Gurwith, Marc; Hendry, Michael; Khan, Arifa S.; Khuri-Bulos, Najwa; Klug, Bettina; Robertson, Jim S.; Seligman, Stephen J.; Sheets, Rebecca; Williamson, Anna-Lise;

Published:

Oct 08 2014

Source:

Vaccine. 33(1):73-75.

Description:

Recombinant viral vectors provide an effective means for heterologous antigen expression in vivo and thus represent promising platforms for developing novel vaccines against human pathogens from Ebola to tuberculosis. An increasing number of candidat...

File Type:

[PDF - 80.67 KB]
Enhancing vaccine safety capacity globally: a lifecycle perspective

Personal Author:

Chen, Robert T.; Shimabukuro, Tom T.; Martin, David B.; Zuber, Patrick L.F.; Weibel, Daniel M.; Sturkenboom, Miriam;

Published:

Oct 01 2015

Source:

Vaccine. 33(0 4):D46-D54

Description:

Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature wit...

File Type:

[PDF - 313.32 KB]
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women

Personal Author:

Jones, Christine E.; Munoz, Flor M.; Spiegel, Hans M.L.; Heininger, Ulrich; Zuber, Patrick L.F.; Edwards, Kathryn M.; Lambach, Philipp; Neels, Pieter; Kohl, Katrin S.; Gidudu, Jane; Hirschfeld, Steven; Oleske, James M.; Khuri-Bulos, Najwa; Bauwens, Jorgen; Eckert, Linda O.; Kochhar, Sonali; Bonhoeffer, Jan; Heath, Paul T.;

Corporate Author:

The Brighton Collaboration Immunization in Pregnancy Working Group

Published:

Jul 29 2016

Source:

Vaccine. 34(49):5998-6006.

Description:

Vaccination during pregnancy is increasingly being used as an effective approach for protecting both young infants and their mothers from serious infections. Drawing conclusions from published studies in this area can be difficult because of the inab...

File Type:

[PDF - 117.17 KB]
DBD bulletin ; issue 15, fall 2014

Corporate Author:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.

Published:

fall 2014

Series:

DBD bulletin ; issue 15

File Type:

[PDF - 1.84 MB]
Live Virus Vaccines Based on a Vesicular Stomatitis Virus (VSV) Backbone: Standardized Template with Key Considerations for a Risk/Benefit Assessment*

Personal Author:

Clarke, David K.; Hendry, R. Michael; Singh, Vidisha; Rose, John K.; Seligman, Stephen J.; Klug, Bettina; Kochhar, Sonali; Mac, Lisa Marie; Carbery, Baevin; Chen, Robert T;

Corporate Author:

For the Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)

Published:

Jul 06 2016

Source:

Vaccine. 34(51):6597-6609.

Description:

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety of live, recombinant viral vaccines incorporating genes from heterologous viral and other microbial pathogens in their genome (so-called "...

File Type:

[PDF - 397.88 KB]